BioSpace News Archive

AscellaHealth, a national specialty pharmacy benefit manager (SPBMTM) serving commercial, Medicare and Medicaid segments, has partnered with The Healthcare Council, an organization of Providers of Care consisting of hospitals and allied health care facilities serving Virginia, Maryland and the District of Columbia, and expanding regions, and its subsidiary corporation ShareSource, to present a virtual education webinar:

“Marc Lustig, founder and former Chairman of Origin House, was the lead investor in this strategic financing. Tryp is pleased to have such a well-known and respected Canadian entrepreneur as an investor.

The new four-part program promotes cleanliness, confidence and compliance allowing facilities to reopen - and stay open - with peace of mind

Celiac disease afflicts millions of Americans, most of whom are undiagnosed, and is second only to end-stage renal disease in perceived burden by patients and caregivers

Data from over 9,000 people reveal a distinct gut microbiome signature that is associated with healthy aging and survival in the latest decades of life.

Stellar Health (“Stellar”), a healthcare technology company leading the way in value-based care delivery, recently announced the appointment of Dr. Catherine Gaffigan, Dr. David Carmouche, Bunny Ellerin, Michael Akinyele, and Dr. John Fitzgerald to its Board of Advisors.

Life Biosciences, a pioneering life sciences company targeting the biology of aging, has in-licensed intellectual property related to scientific findings recently described in two publications in the journal Nature

Quanterix Corporation (NASDAQ: QTRX) , a company digitizing biomarker analysis to advance the science of precision health, today announced that Chairman, Chief Executive Officer and President, Kevin Hrusovsky, will be presenting at the 10 th Annual SVB Leerink Global Healthcare Conference, being held virtually from February 22 – 26, 2021.

Fresenius Kabi Canada, a health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition, announced today it has introduced IDACIO®, an adalimumab biosimilar, in Canada.

PartsSource, the only evidence-based marketplace that combines data-driven decision support with automation to simplify medical device products and services procurement, announces updates to its flagship solution, PartsSource Pro.